Some aspects of the treatment of shock in animals.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000818:Animals; D001794:Blood Pressure; D001803:Blood Transfusion; D002302:Cardiac Output; D004071:Digitalis Glycosides / Q000627:therapeutic use; D005919:Glomerular Filtration Rate; D006493:Heparin / Q000627:therapeutic use; D007263:Infusions, Parenteral; D007545:Isoproterenol / Q000627:therapeutic use; D007668:Kidney / Q000098:blood supply; D010101:Oxygen Consumption; D010952:Plasma Substitutes / Q000008:administration & dosage; D011433:Propranolol / Q000627:therapeutic use; D012039:Regional Blood Flow; D018805:Sepsis / Q000503:physiopathology / Q000662:veterinary; D012769:Shock / Q000628:therapy / Q000662:veterinary*; D012770:Shock, Cardiogenic / Q000503:physiopathology / Q000662:veterinary; D012771:Shock, Hemorrhagic / Q000503:physiopathology / Q000662:veterinary; D012772:Shock, Septic / Q000503:physiopathology / Q000662:veterinary
D000305:Adrenal Cortex Hormones; D004071:Digitalis Glycosides; D010952:Plasma Substitutes; D006493:Heparin; D011433:Propranolol; D007545:Isoproterenol